Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pozzilli

Showing results (71-80 of 187) with videos related to

Pageof 19
Sort By:
Acta Neurologica Scandinavica|October 1, 1992
Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalitiesE Millefiorini, A Padovani, C Pozzilli, et al.
Archives of Neurology|July 1, 1995
Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosisD Toni, M Fiorelli, M Gentile, et al.
Journal of Neurology|March 8, 2003
The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MSA Paolillo, M G Buzzi, E Giugni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MSV Tomassini, L De Giglio, M Reindl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
Prospective study of multiple sclerosis with early onsetA Ghezzi, C Pozzilli, M Liguori, et al.
Stroke|March 1, 1985
Imaging of leukocytic infiltration in human cerebral infarctsC Pozzilli, G L Lenzi, C Argentino, et al.
Journal of the Neurological Sciences|August 13, 1998
A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosisM Filippi, G Mastronardo, S Bastianello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2004
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing studyE Onesti, F Bagnato, V Tomassini, et al.
Neurology|March 23, 2005
Interferon beta-1b treatment does not induce autoantibodiesC H Polman, L Kappos, F Dahlke, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Pageof 19

Showing results (71-80 of 187) with videos related to

Sort By:
Pageof 19
Acta Neurologica Scandinavica|October 1, 1992
Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalitiesE Millefiorini, A Padovani, C Pozzilli, et al.
Archives of Neurology|July 1, 1995
Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosisD Toni, M Fiorelli, M Gentile, et al.
Journal of Neurology|March 8, 2003
The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MSA Paolillo, M G Buzzi, E Giugni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MSV Tomassini, L De Giglio, M Reindl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
Prospective study of multiple sclerosis with early onsetA Ghezzi, C Pozzilli, M Liguori, et al.
Stroke|March 1, 1985
Imaging of leukocytic infiltration in human cerebral infarctsC Pozzilli, G L Lenzi, C Argentino, et al.
Journal of the Neurological Sciences|August 13, 1998
A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosisM Filippi, G Mastronardo, S Bastianello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2004
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing studyE Onesti, F Bagnato, V Tomassini, et al.
Neurology|March 23, 2005
Interferon beta-1b treatment does not induce autoantibodiesC H Polman, L Kappos, F Dahlke, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Pageof 19